Thermodynamic Model of Hyperthermia in Humans Undergoing HIPEC

ConditionHIPEC
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHenry Ford Health System

About this trial

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a well-established alternative for patients with peritoneal surface malignancies. Although HIPEC has a predetermined protocol to manage body temperature, the resultant bladder and core-body temperatures are highly variable and unstable in clinical practice. Such results highlight an incomplete understanding of the thermodynamic processes during HIPEC in humans.

Previous clinical and animal investigations have studied abdominal hyperthermia, but a full human model incorporating patient variables, heat delivery, and the impact of the circulatory system and anesthesia in HIPEC has not been established.

This project seeks to develop and validate a computational thermodynamic model using prospective real-world data from humans undergoing HIPEC surgery. It is hypothesized that by incorporating patient, anesthetic, and perfusion-related variables in a thermodynamic model, the temperatures inside and outside the abdomen during HIPEC can be predicted.

Eligibility criteria

Qualifiers

Adults (at least 18 years or older)

Scheduled to undergo HIPEC surgery for abdominal cancer at HFH-Main

Disqualifiers

Pregnant females

Minors

Disease not amenable for treatment with HIPEC after surgical examination.

Trial design

Treatments tested in this trial

  • Additional temperature monitoring/recording

Treatment groups

30 Participants
are divided into 1 treatment group

Sponsors and collaborators